Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol on Emotional and Cognitive Functions in Healthy Subjects
NCT01957293Phase 2Completed
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of salbutamol. Primary endpoints: Change of emotional memory functions at 10 days and Change of episodic memory functions at 10 days. Started Oct 2013; status: completed.
02
Drugs
salbutamol
Beyond the preview
Go deeper on NCT01957293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01957293.